| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Cannabidiol | Acute Liver Failure | 1 | PM | 21182490 | 📋 | Cannabidiol Improves Brain and Liver Function in a Fulminant Hepatic Failure-Induced Model of Hepatic Encephalopathy in Mice |
| Cannabidiol | Alcoholic Liver Disease | 3 | PM | 34630100 | 📋 | CBD Alleviates Liver Injuries in Alcoholics With High-Fat High-Cholesterol Diet Through Regulating NLRP3 Inflammasome-Pyroptosis Pathway |
| Cannabidiol | Alcoholic Liver Disease | 1 | PM | 28935932 | 📋 | Cannabidiol Attenuates Alcohol-Induced Liver Steatosis, Metabolic Dysregulation, Inflammation and Neutrophil-Mediated Injury |
| Cannabidiol | Alcoholic Liver Disease | 2 | PM | 24398069 | 📋 | Cannabidiol Protects Liver From Binge Alcohol-Induced Steatosis by Mechanisms Including Inhibition of Oxidative Stress and Increase in Autophagy |
| Cannabidiol | Autoimmune Hepatitis | 1 | PM | 19647124 | 📋 | Use of Cannabinoids as a Novel Therapeutic Modality Against Autoimmune Hepatitis |
| Cannabidiol | Biliary Tract Cancer | 2 | PM | 35740979 | 📋 | Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways |
| Cannabidiol | Biliary Tract Cancer | 1 | PM | 19916793 | 📋 | The Dual Effects of delta(9)-tetrahydrocannabinol on Cholangiocarcinoma Cells: Anti-Invasion Activity at Low Concentration and Apoptosis Induction at High Concentration |
| Cannabidiol | Hepatic Cirrhosis | 1 | PM | 29890719 | 📋 | The Role of Cannabinoids in the Setting of Cirrhosis |
| Cannabidiol | Hepatic Encephalopathy | 1 | PM | 21182490 | 📋 | Cannabidiol Improves Brain and Liver Function in a Fulminant Hepatic Failure-Induced Model of Hepatic Encephalopathy in Mice |
| Cannabidiol | Hepatic Fibrosis | 2 | PM | 38711461 | 📋 | Cannabidiol alleviates carbon tetrachloride-induced liver fibrosis in mice by regulating NF-κB and PPAR-α pathways |
| Cannabidiol | Hepatic Fibrosis | 1 | PM | 21654828 | 📋 | Cannabidiol Causes Activated Hepatic Stellate Cell Death Through a Mechanism of Endoplasmic Reticulum Stress-Induced Apoptosis |
| Cannabidiol | Hepatic Ischemia-Reperfusion | 1 | PM | 21930120 | 📋 | Therapeutic Potential of Cannabidiol Against ischemia/reperfusion Liver Injury in Rats |
| Cannabidiol | Hepatitis C | 1 | PM | 28250664 | 📋 | Potential of Cannabidiol for the Treatment of Viral Hepatitis |
| Cannabidiol | Hepatotoxicity | 2 | PM | 37992955 | 📋 | Cannabidiol protects the liver from α-Amanitin-induced apoptosis and oxidative stress through the regulation of Nrf2 |
| Cannabidiol | Hepatotoxicity | 1 | PM | 37591127 | 📋 | Cannabidiol alleviates perfluorooctane sulfonate-induced macrophage extracellular trap mediate inflammation and fibrosis in mice liver |
| Cannabidiol | Liver Cancer | 4 | PM | 38825256 | 📋 | Cannabidiol reverts the malignant phenotype of hepatocellular carcinoma cells via the GPR55/TP53/MAPK axis |
| Cannabidiol | Liver Cancer | 3 | PM | 37568803 | 📋 | Cannabidiol Enhances Cabozantinib-Induced Apoptotic Cell Death via Phosphorylation of p53 Regulated by ER Stress in Hepatocellular Carcinoma |
| Cannabidiol | Liver Cancer | 2 | PM | 34350183 | 📋 | A Novel Mechanism of Cannabidiol in Suppressing Hepatocellular Carcinoma by Inducing GSDME Dependent Pyroptosis |
| Cannabidiol | Liver Cancer | 1 | PM | 21475304 | 📋 | Anti-tumoral Action of Cannabinoids on Hepatocellular Carcinoma: Role of AMPK-dependent Activation of Autophagy |
| Cannabidiol | Liver Damage | 1 | PM | 21930120 | 📋 | Therapeutic Potential of Cannabidiol Against ischemia/reperfusion Liver Injury in Rats |
| Cannabidiol | Liver Disease | 1 | PM | 38397045 | 📋 | The Role of Cannabidiol in Liver Disease: A Systemic Review |
| Cannabidiol | MAFLD | 1 | PM | 28441459 | 📋 | Cannabis Use Is Associated With Reduced Prevalence of Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study |
| Cannabidiol | MAFLD | 2 | PM | 25595882 | 📋 | Two Non-Psychoactive Cannabinoids Reduce Intracellular Lipid Levels and Inhibit Hepatosteatosis |
| Cannabidiol | Non-Alcoholic Steatohepatitis | 1 | PM | 31032942 | 📋 | Cannabidiol Protects Livers Against Nonalcoholic Steatohepatitis Induced by High-Fat High Cholesterol Diet via Regulating NF-κB and NLRP3 Inflammasome Pathway |
